Speaker illustration

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

John Deanfield CBE is Professor of Cardiology at University College London (UCL) and Director of National Institute for Cardiovascular Outcomes Research (NICOR) which incorporates the national databases for cardiovascular outcomes. Deanfield undertook his training at Churchill College, Cambridge, the Middlesex, Hammersmith and Great Ormond Street Hospitals, London. His principal interests are vascular medicine, opportunities for lifetime management of cardiovascular risk and large scale cardiovascular outcomes research. He has been at the forefront in describing the impact of obesity, cholesterol, diabetes, smoking and other risk factors on health in later life, through coordination of multiple large longitudinal cardiovascular studies in population throughout lifetime. He Chaired the Joint British Societies (JBS3) National Guidelines for Cardiovascular Disease Prevention (2014) and led the development of the public facing Heart Age Tool (2015). He was awarded the British Cardiac Soci

Evolution of coronary artery disease diagnosis ... from stenosis to inflammation

Event: ESC Congress 2024

Topic: Coronary Computed Tomography Angiography (Coronary CTA, CCTA)

Session type: Satellite Symposium

Thumbnail

The weight of cardiovascular risk: addressing obesity in cardiac patients

Event: ESC Preventive Cardiology 2024

Topic: Obesity

Session type: Satellite Symposium

Thumbnail

Weight loss as a therapeutic target in HFpEF: dawn of a new era?

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Novel weight loss strategies to reduce cardiovascular risk in obesity

Event: ESC Congress 2023

Topic: Obesity

Session type: Satellite Symposium

Thumbnail

Perivascular adipose tissue and coronary heart disease: how significant is the link?

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session type: Symposium

Thumbnail

Obesity and CV disease – Lowering CV risk with novel weight loss strategies

Event: ESC Congress 2022

Topic: Obesity and Diabetes

Session type: Satellite Symposium

Thumbnail

Navigating obesity treatment for prevention of CVD

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

Improving cardiovascular risk management in patients with obesity

Event: ESC Congress 2020

Topic: Obesity

Session type: Industry Q&A session

Thumbnail

Managing the burden of cardiovascular disease: time to focus on obesity care (Accredited by EACCME)

Event: ESC Congress 2020

Topic: Obesity

Session type: Industry Q&A session

Thumbnail

Impact of novel guidelines: transforming diabetes management in cardiology

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by